High-throughput sequencing, which is commonly referred to as next-generation sequencing (NGS), has developed into a critical tool in life science research. It is also the chief technology that has enabled the advance of precision medicine, which aims to tailor medical treatments to the individual characteristics of each patient and their disease by taking into account genetic and biomarker traits. As NGS technologies have evolved while simultaneously becoming more affordable and accessible, demand for sequencing, and by necessity demand for preanalytical NGS sample preparation, is rapidly expanding, growing at a double-digit pace. For the companies that supply the reagents and instruments necessary for the preparation of samples for sequencing, this space remains a tremendous source of growth, particularly as clinical adoption accelerates and third-party payors become more accepting of sequencing as a medical necessity.
The Sample Preparation for Next-Generation Sequencing report is an in-depth analysis of the major technologies and products critical in each step of NGS sample prep, namely nucleic acid preparation, fragmentation, and library preparation and target enrichment. The report examines the total NGS sample prep market, including both research laboratory use and clinical use, and provides forecasts for demand over the next five years, segmented by product type, industry, region, and application.
Objectives of this Report
- Market data on the crucial sample and library preparation markets that feed into the NGS market.
- Technology breakdown of the market by specific product and applications types, including nucleic acid prep, fragmentation, and various library preparation and target enrichment options.
- Market demand segmented by product type, region, industry, and application.
- Market demand forecasts through 2023.
- Competitive landscape of vendors participating in each technology.
- Information on opportunities and threats in the marketplace.
Table of Contents
Samples
LOADING...
Companies Mentioned
- 10x Genomics
- Agilent
- Beckman Coulter (Danaher)
- Bio-Rad
- Branson (Emerson)
- Covaris
- GE Healthcare
- Illumina
- Integrated DNA Technologies (Danaher)
- MilliporeSigma
- New England Biolabs
- Oxford Nanopore
- Pacific Biosciences
- QIAGEN
- Roche
- Takara Bio
- Thermo Fisher